Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells

被引:16
作者
Kaneko, H
Neoh, LP
Takeda, N
Akimoto, H
Hishikawa, T
Hashimoto, H
Hirose, S
Karaki, S
Takiguchi, M
Nakauchi, H
Kaneko, Y
Yamamoto, N
Sekigawa, I
机构
[1] JUNTENDO UNIV,SCH MED,DEPT INTERNAL MED & RHEUMATOL,BUNKYO KU,TOKYO 113,JAPAN
[2] TOKYO MED & DENT UNIV,SCH MED,DEPT MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN
[3] UNIV TOKYO,INST MED SCI,DEPT TUMOR BIOL,MINATO KU,TOKYO 108,JAPAN
[4] UNIV TSUKUBA,INST BASIC MED SCI,DEPT IMMUNOL,TSUKUBA,IBARAKI 305,JAPAN
[5] UNIV TSUKUBA,TARA,TSUKUBA,IBARAKI 305,JAPAN
[6] AJINOMOTO CO INC,TOKYO 104,JAPAN
[7] JUNTENDO UNIV,IZU NAGAOKA HOSP,DEPT MED,IZU NAGAOKA,SHIZUOKA 41022,JAPAN
关键词
D O I
10.1128/JVI.71.11.8918-8922.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report here that human immunodeficiency virus type 2 (HIV-2) envelope glycoprotein (gp105), but not HTV-1 gp120, can bind to CD8 molecules as well as to CD4 molecules on human T cells. This phenomenon may lead to differences in the life cycles of HIV-1 and HIV-2, and it may be related to the differences in disease manifestations of HIV-1 and HIV-2 infection, including longer survival of HIV-2-infected patients.
引用
收藏
页码:8918 / 8922
页数:5
相关论文
共 42 条
[1]   ENHANCEMENT OF SIV INFECTION WITH SOLUBLE RECEPTOR MOLECULES [J].
ALLAN, JS ;
STRAUSS, J ;
BUCK, DW .
SCIENCE, 1990, 247 (4946) :1084-1088
[2]  
ANDREASSON PA, 1993, AIDS, V7, P989, DOI 10.1097/00002030-199307000-00013
[3]   STUDY OF THE INTERACTION OF HIV-1 AND HIV-2 ENVELOPE GLYCOPROTEINS WITH THE CD4 RECEPTOR AND ROLE OF N-GLYCANS [J].
BAHRAOUI, E ;
BENJOUAD, A ;
GUETARD, D ;
KOLBE, H ;
GLUCKMAN, JC ;
MONTAGNIER, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) :565-573
[4]   HIV SUPPRESSION BY INTERLEUKIN-16 [J].
BAIER, M ;
WERNER, A ;
BANNERT, N ;
METZNER, K ;
KURTH, R .
NATURE, 1995, 378 (6557) :563-563
[5]  
BARIN F, 1985, LANCET, V2, P1387
[6]   EFFECTS OF T(H)1 AND T(H)2 CYTOKINES ON CD8(+) CELL RESPONSE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS - IMPLICATIONS FOR LONG-TERM SURVIVAL [J].
BARKER, E ;
MACKEWICZ, CE ;
LEVY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11135-11139
[7]   CHARACTERIZATION OF INVITRO INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS BY PURIFIED RECOMBINANT CD4 [J].
BYRN, RA ;
SEKIGAWA, I ;
CHAMOW, SM ;
JOHNSON, JS ;
GREGORY, TJ ;
CAPON, DJ ;
GROOPMAN, JE .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4370-4375
[8]  
CEFAI D, 1992, J IMMUNOL, V149, P285
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION AND FUSION OF CD4-NEGATIVE HUMAN CELL-LINES - INDUCTION AND ENHANCEMENT BY SOLUBLE CD4 [J].
CLAPHAM, PR ;
MCKNIGHT, A ;
WEISS, RA .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3531-3537
[10]   SOLUBLE CD4 BLOCKS THE INFECTIVITY OF DIVERSE STRAINS OF HIV AND SIV FOR T-CELLS AND MONOCYTES BUT NOT FOR BRAIN AND MUSCLE-CELLS [J].
CLAPHAM, PR ;
WEBER, JN ;
WHITBY, D ;
MCINTOSH, K ;
DALGLEISH, AG ;
MADDON, PJ ;
DEEN, KC ;
SWEET, RW ;
WEISS, RA .
NATURE, 1989, 337 (6205) :368-370